Agilent and SomaLogic Sign Agreement for Supply of Custom Microarrays

08:00 EDT 30 Apr 2019 | Businesswire
This article has expired, however you can still download the PDF.
Use of Agilent’s custom microarrays in the SOMAscan® assay will help drive biomarker discovery efforts as well as novel diagnostics and accelerated pharmaceutical development Agilent Technologies, Inc. (NYSE: A) an...

Other Sources for this Article

Naomi Goumillout
Agilent Technologies, Inc.
Laura S. Mizoue, Ph.D.
SomaLogic, Inc.


More From BioPortfolio on "Agilent and SomaLogic Sign Agreement for Supply of Custom Microarrays"

Quick Search

Relevant Topics

An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...